Common side effects of everolimus (Afinitor) and precautions for safe use

1. Overview of Drugs

Everolimus (Everolimus) is an oral mammalian target of rapamycin inhibitor (mTOR inhibitor). It prevents cell proliferation and angiogenesis by inhibiting the mTOR signaling pathway, thereby exerting anti-tumor and immunosuppressive effects. Clinically, it is mainly used to treat renal cell carcinoma, breast cancer, neuroendocrine tumors and organ transplant rejection. Everolimus is used in the form of oral tablets and has good bioavailability. However, because its action involves multiple signaling pathways, there are many potential side effects and safety issues that need to be paid attention to during administration.

2. Common side effects

1. Blood system effects: Everolimus may cause bone marrow suppression such as leukopenia, thrombocytopenia, and anemia. Clinical data shows that such side effects occur more frequently in patients, especially when combined with chemotherapy or long-term medication. It is recommended that patients undergo routine blood tests before taking medication and during each cycle to detect hematological abnormalities in a timely manner.

2. Metabolic and endocrine abnormalities: Common side effects include hyperglycemia, hyperlipidemia, hypokalemia, etc. Especially for patients with diabetes or hyperlipidemia, blood sugar and blood lipids may increase significantly while taking everolimus. Dietary control and drug intervention are required to ensure the stability of metabolic indicators.

3.Digestive system reactions: Oral ulcers, diarrhea, nausea, and vomiting are common adverse reactions, among which oral mucositis and oral ulcers are the most prominent, affecting patients' daily diet and quality of life. Symptoms can be relieved with topical oral care, the use of oral rinses, or topical medications.

4.Increased risk of infection: Everolimus has an immunosuppressive effect, and patients are prone to upper respiratory tract infections, pneumonia, skin infections and viral infections while taking the drug. Especially for patients with low immunity, infection prevention and control measures need to be strengthened, such as avoiding crowded places, paying attention to hand hygiene, and timely vaccination of appropriate vaccines (under the guidance of a doctor).

5.Skin and mucous membrane reactions: including rash, itching, hair loss, brittle nails, etc. It is generally mild to moderate and can be alleviated through topical skin care and symptomatic treatment. A few patients may need to adjust the dosage or discontinue medication.

6.Other adverse reactions: also include fatigue, joint pain, dry mouth and mild liver function abnormalities. Patients with abnormal liver function need to monitor liver enzyme levels and adjust the dose or delay administration according to the situation.

3. Precautions for safe use

1. Strictly follow the doctor's instructions when taking medication: the dose of everolimus needs to be adjusted individually based on the patient's body surface area or weight and specific indications. Do not increase or decrease the dose on your own. It is usually taken once a day, preferably at a fixed time every day to maintain stable blood concentration.

2.Regular monitoring indicators: Blood routine, liver function, kidney function, blood sugar and blood lipids need to be monitored regularly during medication, and the medication plan should be adjusted in a timely manner based on the monitoring results. For patients taking long-term medication, cardiovascular function and pulmonary function also need to be followed up for evaluation.

3.Interactions between diet and drugs: Everolimus is mainly metabolized by the liverCYP3A4, so avoid using it with grapefruit and drugs containing CYP3A4 inhibition or induction to avoid abnormal blood drug concentrations. Patients should follow a low-fat, balanced diet and avoid alcohol and high-calorie diets that affect metabolism.

4.Infection protection and life management: Patients should maintain good personal hygiene while taking the medicine, avoid sources of infection, pay attention to oral hygiene, and seek medical attention in time if they have fever, cough or other infection symptoms. If serious infection or abnormal blood indicators occur, the drug needs to be discontinued or the dose adjusted.

5. Precautions during pregnancy and lactation: Everolimus may have adverse effects on the fetus and is contraindicated in pregnant women. Women of childbearing age need to take effective contraceptive measures. Use with caution during breastfeeding and suspend breastfeeding if necessary.

4. Medication management and clinical suggestions

Everolimus, as an mTOR inhibitor, has significant efficacy in a variety of malignant tumors and immunosuppressive treatment, but safety must be paid full attention to. Patients should undergo a comprehensive evaluation before taking the drug, including blood, liver and kidney function, and cardiopulmonary function, and should be followed up regularly during treatment. For side effects that occur, intervention should be carried out through dose adjustment, symptom management, or combined medication. Standardized and individualized medication management can minimize risks while ensuring efficacy, and improve patients' quality of life and treatment compliance.

Reference materials:https://www.drugs.com/